share_log

Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?

Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?

紐約批准了一項重大的大麻股合併:大麻股投資者能否抓住機會?
Benzinga ·  10/11 05:21

RIV Capital Inc. (CSE:RIV) (OTC:CNPOF) and Cansortium Inc. (CSE:TIUM) (OTCQB:CNTMF) have secured approval from the New York Cannabis Control Board for their upcoming merger, marking a major consolidation in the state's fast-growing cannabis industry.

RIV Capital Inc. (CSE:RIV)(OTC:CNPOF)和Cansortium Inc.(CSE:TIUM)(OTCQB:CNTMF)已獲得紐約大麻股管理局批准進行即將到來的合併,標誌着該州快速增長的大麻行業即將發生重大整合。

The merger, expected to close by the end of 2024, positions the combined company to take full advantage of covering 25% of the U.S. population with eight cultivation and processing facilities and 42 retail dispensaries.

預計合併將於2024年底完成,使合併後的公司能充分利用覆蓋美國25%人口的優勢,擁有8個種植加工設施和42家零售藥店。

"We are thrilled to have received regulatory approval in New York to move forward with our business combination transaction, bringing us closer to completing this important step for both of our companies in the fourth quarter of 2024," said Robert Beasley, CEO of Cansortium, in a press release Thursday afternoon.

「我們很高興獲得紐約的監管機構批准,以推動我們的業務組合交易,使我們更接近於在2024年第四季度完成兩家公司的重要步驟,」Cansortium首席執行官羅伯特·比斯利在週四下午的新聞發佈會上表示。

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you're serious about the business.
  • 在Benzinga獲取獨家分析,並每天免費獲得關於大麻業務和市場的頭條新聞。立即訂閱我們的通訊,認真對待業務,您不容錯過。

New York's Cannabis Boom

紐約的大麻繁榮

With adult-use cannabis sales now in full swing, New York has quickly become a battleground for companies looking to expand their market share. RIV Capital, which operates three retail locations in the state, has seen rapid growth in both its consumer-facing and wholesale businesses since adult-use sales began earlier this year.

隨着成年人使用大麻銷售進入全面推廣,紐約迅速成爲企業競相擴大市場份額的戰場。在該州經營三家零售店的RIV Capital自今年早些時候開始成年人使用銷售以來,其面向消費者和批發業務都實現了快速增長。

Cansortium, a vertically integrated company operating under the FLUENT brand, brings significant expertise from other key markets, including Florida, Pennsylvania, and Texas.

作爲一家在FLUENt品牌下運營的垂直一體化公司,Cansortium在佛羅里達、賓夕法尼亞和德克薩斯等其他關鍵市場擁有重要經驗。

Read Also: EXCLUSIVE: 80% Growth Despite The Chaos: How Dutchie, C3 Defy 2024's Cannabis Slump

閱讀更多:獨家報道:儘管混亂,Dutchie、C3仍然實現了80%的增長:如何抵禦2024年的大麻低迷

What This Means For Investors

對投資者意味着什麼

For cannabis investors, this merger signals a unique opportunity to gain exposure to a rapidly expanding market. RIV Capital's partnership with The Hawthorne Collective, a subsidiary of ScottsMiracle-Gro (NYSE:SMG), further strengthens its position in the cannabis supply chain. Meanwhile, Cansortium's operational expertise in cultivation, production and retail will likely drive significant value for shareholders.

對於大麻股投資者,這次合併預示着一個獨特的機會,可以在一個快速擴張的市場中獲得曝光。RIV Capital與ScottsMiracle-Gro(紐交所:SMG)旗下的The Hawthorne Collective合作,進一步鞏固了其在大麻供應鏈中的地位。與此同時,Cansortium在種植、生產和零售方面的運營專業知識可能會爲股東帶來顯著價值。

Closing Timeline And Further Details

結束時間表和更多細節

  • The merger between RIV Capital and Cansortium is expected to close by the fourth quarter of 2024, pending final closing conditions.
  • Upon completion, Cansortium's shares will continue trading on the Canadian Securities Exchange under the symbol 'TIUM.U' and on the OTCQB Venture Market under 'CNTMF.'
  • Further details, including the principal closing conditions, can be found in RIV Capital's management information circular dated July 12, 2024.
  • 預計RIV Capital和Cansortium之間的合併將在2024年第四季度完成,待最終交易條件滿足。
  • 完成後,Cansortium的股票將繼續在加拿大證券交易所以「TIUm.U」爲標的以及在場外交易OTCQb創業公司市場以「CNTMF」爲標的上交易。
  • 有關主要交易條件的進一步細節可在2024年7月12日的RIV Capital管理信息披露文件中找到。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論